Cullen, Nicholas C.
Leuzy, Antoine
Janelidze, Shorena
Palmqvist, Sebastian http://orcid.org/0000-0002-9267-1930
Svenningsson, Anna L.
Stomrud, Erik
Dage, Jeffrey L. http://orcid.org/0000-0002-2192-1699
Mattsson-Carlgren, Niklas
Hansson, Oskar http://orcid.org/0000-0001-8467-7286
Article History
Received: 14 January 2021
Accepted: 10 May 2021
First Online: 11 June 2021
Competing interests
: N.C.C., A.L., S.J., S.P., E.S., N.M.C., and A.L.S. report no disclosures. J.L.D. is an employee and stockholder of Eli Lilly and Company. O.H. has acquired research support (for the institution) from AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, GE Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from AC Immune, Alzpath, Biogen, Cerveau and Roche.